Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples
Phone801-345-1000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.68 billion
Profitability
Miscellaneous
Employees4,900
Next Earnings Date4/25/2019 (Estimated)
OptionableOptionable
Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions
What is Nu Skin Enterprises' stock symbol?
Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."
How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?
Nu Skin Enterprises announced a quarterly dividend on Thursday, February 14th. Investors of record on Monday, February 25th will be paid a dividend of $0.37 per share on Wednesday, March 13th. This represents a $1.48 dividend on an annualized basis and a yield of 3.12%. The ex-dividend date is Friday, February 22nd. This is a boost from Nu Skin Enterprises's previous quarterly dividend of $0.37. View Nu Skin Enterprises' Dividend History.
How were Nu Skin Enterprises' earnings last quarter?
Nu Skin Enterprises, Inc. (NYSE:NUS) issued its quarterly earnings data on Wednesday, February, 13th. The company reported $1.05 EPS for the quarter, meeting analysts' consensus estimates of $1.05. The firm earned $683.29 million during the quarter, compared to analysts' expectations of $676.76 million. Nu Skin Enterprises had a net margin of 4.55% and a return on equity of 25.98%. Nu Skin Enterprises's revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.20 EPS. View Nu Skin Enterprises' Earnings History.
When is Nu Skin Enterprises' next earnings date?
What guidance has Nu Skin Enterprises issued on next quarter's earnings?
Nu Skin Enterprises issued an update on its FY19 earnings guidance on Wednesday, February, 13th. The company provided earnings per share guidance of $3.80-4.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.02. The company issued revenue guidance of $2.76-2.82 billion, compared to the consensus revenue estimate of $2.77 billion.Nu Skin Enterprises also updated its FY 2019 guidance to $3.80-4.05 EPS.
What price target have analysts set for NUS?
8 analysts have issued 1 year target prices for Nu Skin Enterprises' stock. Their forecasts range from $43.00 to $92.00. On average, they expect Nu Skin Enterprises' share price to reach $77.1429 in the next year. This suggests a possible upside of 62.6% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.
What is the consensus analysts' recommendation for Nu Skin Enterprises?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 2 sell ratings, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nu Skin Enterprises.
What are Wall Street analysts saying about Nu Skin Enterprises stock?
Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
- 1. Pivotal Research analysts commented, "We do expect share repurchase to accelerate and contribute meaningfully to 2019 and 2020. In 2018 diluted shares rose 2.3% compared to -2% in 2017; and -4.9% in 2016. NUS loves to shrink its share count. We think 2019 might be bigger than usual which is not in the guidance. We find the multi-year prospects for NUS shares to be excellent. Top line growth and expanding EBIT margins, accelerating share repurchases and a tax rate that may drift lower sets the stage for double-digit gains in EPS for many years. Management is excellent and improving the speed to market and technology of the business. It really is a near-perfect setup." (2/13/2019)
- 2. According to Zacks Investment Research, "Nu Skin shares have increased in the past three months. We note that the company has been steadily gaining from expanding sales leaders and customers globally. Notably, these upsides aided third-quarter results, marking Nu Skin’s fourth consecutive period of year-on-year top- and bottom-line growth. Moreover, the stellar quarterly show encouraged management to raise 2018 revenue projections. Additionally, the company is on track with expanding its sales compensation program Velocity across different nations. However, dismal gross margins and adverse impacts from currency fluctuations have been a worry for the company. In fact, the company’s gross margin has been slipping since the past several quarters. Further, currency translations is expected to continue denting Nu Skin’s bottom-line in 2018. Nevertheless, we note that the company’s earnings estimate for the fourth quarter have remained stable lately." (2/12/2019)
- 3. Jefferies Financial Group Inc analysts commented, "We hosted NUS senior leaders for a series of meetings last week. While our view of China macro beauty has tempered somewhat in recent months, we walked away from meetings with a more optimistic sense of China skincare device sales potential and global benefits from product innovation (new & extensions), program enhancements (including sales comp structure), and a growing level of sophistication around social selling that sets NUS apart from other MLM companies." (9/4/2018)
Has Nu Skin Enterprises been receiving favorable news coverage?
News coverage about NUS stock has trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nu Skin Enterprises earned a news sentiment score of -1.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near future.
Are investors shorting Nu Skin Enterprises?
Nu Skin Enterprises saw a increase in short interest in February. As of February 15th, there was short interest totalling 2,390,902 shares, an increase of 53.4% from the January 31st total of 1,558,860 shares. Based on an average trading volume of 755,405 shares, the days-to-cover ratio is currently 3.2 days. Currently, 4.6% of the company's stock are short sold. View Nu Skin Enterprises' Current Options Chain.
Who are some of Nu Skin Enterprises' key competitors?
What other stocks do shareholders of Nu Skin Enterprises own?
Who are Nu Skin Enterprises' key executives?
Nu Skin Enterprises' management team includes the folowing people:
- Mr. Steven J. Lund, Exec. Chairman (Age 66)
- Mr. Ritch N. Wood, CEO & Director (Age 53)
- Mr. Ryan S. Napierski, Pres (Age 45)
- Mr. Mark H. Lawrence, Exec. VP & CFO (Age 49)
- Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 66)
Who are Nu Skin Enterprises' major shareholders?
Nu Skin Enterprises' stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (11.29%), Dimensional Fund Advisors LP (2.05%), Norges Bank (1.65%), APG Asset Management N.V. (1.64%), MERIAN GLOBAL INVESTORS UK Ltd (1.46%) and Bank of New York Mellon Corp (1.39%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Daniel W Campbell, Edwina D Woodbury, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.
Which major investors are selling Nu Skin Enterprises stock?
NUS stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Two Sigma Investments LP, Bank of New York Mellon Corp, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, California Public Employees Retirement System, GSA Capital Partners LLP, Two Sigma Advisers LP and Hsbc Holdings PLC. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, Edwina D Woodbury, Joseph Y Chang, Neil H Offen, Ryan S Napierski and Steven Lund. View Insider Buying and Selling for Nu Skin Enterprises.
Which major investors are buying Nu Skin Enterprises stock?
NUS stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, BlackRock Inc., SG Capital Management LLC, Canada Pension Plan Investment Board, D. E. Shaw & Co. Inc., Millennium Management LLC, MERIAN GLOBAL INVESTORS UK Ltd and Bank of Montreal Can. View Insider Buying and Selling for Nu Skin Enterprises.
How do I buy shares of Nu Skin Enterprises?
Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nu Skin Enterprises' stock price today?
One share of NUS stock can currently be purchased for approximately $47.44.
How big of a company is Nu Skin Enterprises?
Nu Skin Enterprises has a market capitalization of $2.63 billion and generates $2.68 billion in revenue each year. The company earns $121.88 million in net income (profit) each year or $3.52 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe.
What is Nu Skin Enterprises' official website?
How can I contact Nu Skin Enterprises?
Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]
MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
